scholarly journals Development and Initial feasibility of an Online Cognitive Behavioral Group Intervention for COVID-19 Related Distress

2021 ◽  
Author(s):  
Eamon Aswad ◽  
Keith Gaynor
Keyword(s):  
Cognitive Behavioral Therapy ◽  
Behavioral Therapy ◽  
Intervention Development ◽  
Cognitive Behavioral ◽  
Retention Rates ◽  
Post Intervention ◽  
Online Data ◽  
Maintenance Factors ◽  
Therapy Intervention ◽  
Online Group

Objective: The COVID-19 pandemic has resulted in an increase in adverse psychological outcomes world-wide. This paper discusses the development of a manualised online group Cognitive Behavioral Therapy intervention in a secondary care setting targeting the maintenance factors of COVID-19 related distress. Method: This paper details (i) the development of the intervention using the six steps in quality intervention development (6SQuID; Wight, Wimbush, Jepson & Doi, 2016) methodology (ii) a mixed-method feasibility study exploring a manualised online group Cognitive Behavioral Therapy intervention targeting the maintenance factors of COVID-19 related distress.Results: Using the 6SQuID methodology, a theoretical coherent, novel intervention, which did not replicate existing treatment designs, was developed. In relation to feasibility, engagement with this remote group program was poor. There were low levels of engagement in online data-gathering, making it difficult to ascertain indicators of effectiveness. In relation to acceptability, retention rates of participants were high. Participants described a high level of treatment appropriateness and positive post-intervention change.Conclusion: A theoretically coherent manualised treatment was developed. It did not meet initial assessments of feasibility, though it did meet qualitative and quantitative measures of acceptability.

scholarly journals The Efficacy of Transdiagnostic Cognitive Behavioral Therapy on Migraine Headache: A Randomized Clinical Trial

2022 ◽  
Author(s):  
Forouzandeh Soleimanian-Boroujeni ◽  
Negin Badihian ◽  
Shervin Badihian ◽  
Vahid Shaygannejad ◽  
Yousef Gorji
Keyword(s):  
Cognitive Behavioral Therapy ◽  
Behavioral Therapy ◽  
Intervention Group ◽  
Cognitive Behavioral ◽  
Control Group ◽  
Post Intervention ◽  
Therapy Termination ◽  
Protocol Registration ◽  
And Control

Abstract Introduction: Psychological interventions are shown to be effective in migraine, but not utilized routinely yet. We aimed to evaluate the efficacy of transdiagnostic cognitive behavioral therapy (TCBT) on people with migraine (PwM). Method: This study was conducted on 40 PwM aged 20-50 years. We randomly assigned participants to two groups of intervention, receiving 10 sessions of TCBT, and control. Days with headache, headache severity, migraine-related disability and effects on daily life, number of pain-relivers taken for headache, depression, and anxiety were assessed pre-intervention, post-intervention (three-month follow-up), and one-month after TCBT termination (four-month follow-up).Results: Thirty-five participants suffering moderate to severe migraine completed the study (16 and 19 in TCBT and control groups, respectively). TCBT improved all measured items between study time-points (p<0.05) in the intervention group, while such an improvement was not observed in the control group. Between group comparisons revealed superiority of TCBT group compared to the control group in most measured items at three- and four-month follow-ups (p<0.05).Conclusion: Ten sessions of TCBT improved migraine severity, associated disability, anxiety, and depression in PwM, with persistent effects after one month of therapy termination. TCBT is an affordable, practical, and feasible intervention to be utilized for PwM.Protocol registration: The study protocol was registered in clinicaltrial.gov (NCT03701477) prior to enrollment.

scholarly journals A pilot study of an exercise & cognitive behavioral therapy intervention for epithelial ovarian cancer patients

2013 ◽  
Vol 6 (1) ◽  
pp. 21 ◽  
Author(s):  
Shalini H Moonsammy ◽  
Crissa L Guglietti ◽  
Daniel Santa Mina ◽  
Sarah Ferguson ◽  
Jennifer L Kuk ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Pilot Study ◽  
Cognitive Behavioral Therapy ◽  
Epithelial Ovarian Cancer ◽  
Cancer Patients ◽  
Behavioral Therapy ◽  
Cognitive Behavioral ◽  
Therapy Intervention

scholarly journals Cognitive behavioral therapy positively affects fatigue in patients with multiple sclerosis: Results of a randomized controlled trial

2017 ◽  
Vol 23 (11) ◽  
pp. 1542-1553 ◽  
Author(s):  
Lizanne E van den Akker ◽  
Heleen Beckerman ◽  
Emma H Collette ◽  
Jos WR Twisk ◽  
Gijs Bleijenberg ◽  
...  
Keyword(s):  
Multiple Sclerosis ◽  
Randomized Controlled Trial ◽  
Cognitive Behavioral Therapy ◽  
Behavioral Therapy ◽  
Controlled Trial ◽  
Cognitive Behavioral ◽  
Control Treatment ◽  
Post Intervention ◽  
Randomized Controlled ◽  
Societal Participation

Background: Fatigue is a common symptom in multiple sclerosis (MS) and often restricts societal participation. Cognitive behavioral therapy (CBT) may alleviate MS-related fatigue, but evidence in literature is inconclusive. Objective: To evaluate the effectiveness of CBT to improve MS-related fatigue and participation. Methods: In a multi-center, assessor-masked, randomized controlled trial, participants with severe MS-related fatigue were assigned to CBT or control treatment. CBT consisted of 12 individual sessions with a psychologist trained in CBT, the control treatment consisted of three consultations with a MS nurse, both delivered over 16 weeks. Assessments were at baseline, 8, 16 (i.e. post-intervention), 26, and 52 weeks post-baseline. Primary outcomes were the Checklist Individual Strength-fatigue subscale (CIS20r fatigue) and the Impact on Participation and Autonomy questionnaire (IPA). Data were analyzed according to the intention-to-treat principle, using mixed-model analysis. Results: Between 2011 and 2014, 91 patients were randomized (CBT: n = 44; control: n = 47). Between-group analysis showed a positive post-intervention effect for CBT on CIS20r fatigue (T16: −6.7 (95% confidence interval (CI) = −10.7; −2.7) points) that diminished during follow-up (T52: 0.5 (95% CI = −3.6; 4.4)). No clinically relevant effects were found on societal participation. Conclusion: Severe MS-related fatigue can be reduced effectively with CBT in the short term. More research is needed on how to maintain this effect over the long term.

Videoconference-Based Cognitive Behavioral Therapy in Symptomatic Panic Disorder Following Primary Pharmacotherapy: Randomized, Assessor-Blinded, Controlled Trial (Preprint)

2021 ◽  
Author(s):  
Yoichi Seki ◽  
Ryo Takemura ◽  
Chihiro Sutoh ◽  
Remi Noguchi ◽  
Yoko Okamoto ◽  
...  
Keyword(s):  
Panic Disorder ◽  
Cognitive Behavioral Therapy ◽  
Medical Information ◽  
Behavioral Therapy ◽  
Controlled Trial ◽  
Standard Of Care ◽  
Cognitive Behavioral ◽  
University Hospital ◽  
Open Label ◽  
Post Intervention

BACKGROUND Background: Given the difficulty in accessing cognitive behavioral therapy, pharmacotherapy remains the standard of care for panic disorder (PD). OBJECTIVE Objectives: This study aimed to determine the effectiveness of videoconference-based cognitive behavioral therapy (VCBT) for patients who remain symptomatic after primary pharmacotherapy as an adjunct to usual care (UC) when compared with UC alone. METHODS Methods: This prospective, randomized, open-label endpoint trial enrolled 30 patients with PD who did not respond to primary pharmacotherapy, including antidepressants and anxiolytics, after ≥8 weeks of therapy, who underwent VCBT (n=15) or UC (n=15) between November 2017 and March 2020 at Chiba University Hospital in Chiba, Japan. They were evaluated at screening, week 0 (baseline), week 8 (mid-intervention), and week 16 (post-intervention). The primary outcome was the change in the PD Severity Scale (PDSS) score at week 16 from baseline. RESULTS Results: After 16 weeks, the adjusted mean changes in the PDSS score from baseline were −7.92 and 0.75 in the VCBT and UC groups, respectively, with a between-group difference of −8.67 (95% CI: −11.80 to −5.54, P<.0001). A higher proportion of patients in the VCBT group responded to treatment (≥40% reduction in the PDSS score at week 16) and experienced remission (PDSS score <8 points at week 8) than those in the UC group (P<.0001). CONCLUSIONS Conclusions: Our results suggest that VCBT is an effective treatment adjunct to UC in patients with PD who remain symptomatic following primary pharmacotherapy and improves PD symptoms in these patients. CLINICALTRIAL Trial Registration: University Hospital Medical Information Network Clinical Trials Registry UMIN000029987; https://upload.umin.ac.jp/cgi-open-bin/ctr/ctr_view.cgi?recptno=R000034247.

Sign in / Sign up

Export Citation Format

Share Document